Aurora Cannabis (NYSE:ACB) Lowered to Sell at Zacks Investment Research

Share on StockTwits

Zacks Investment Research downgraded shares of Aurora Cannabis (NYSE:ACB) from a buy rating to a sell rating in a research note released on Thursday, Zacks.com reports.

According to Zacks, “Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company’s purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. “

ACB has been the topic of several other reports. Stifel Nicolaus assumed coverage on shares of Aurora Cannabis in a report on Wednesday, June 5th. They set a hold rating on the stock. ValuEngine lowered shares of Aurora Cannabis from a buy rating to a hold rating in a report on Friday, August 2nd. LADENBURG THALM/SH SH assumed coverage on shares of Aurora Cannabis in a report on Wednesday, July 17th. They set a buy rating and a $9.00 price target on the stock. Piper Jaffray Companies assumed coverage on shares of Aurora Cannabis in a report on Monday, August 12th. They set a neutral rating and a $7.00 price target on the stock. Finally, Compass Point assumed coverage on shares of Aurora Cannabis in a report on Monday, July 8th. They set a neutral rating on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus target price of $8.23.

Shares of Aurora Cannabis stock opened at $5.99 on Thursday. The firm has a market capitalization of $5.77 billion, a PE ratio of 49.92 and a beta of 2.44. The company has a current ratio of 2.37, a quick ratio of 1.98 and a debt-to-equity ratio of 0.10. The firm’s 50 day moving average is $6.84 and its 200 day moving average is $7.88. Aurora Cannabis has a 1 year low of $4.58 and a 1 year high of $12.52.

A number of institutional investors and hedge funds have recently bought and sold shares of ACB. Moisand Fitzgerald Tamayo LLC bought a new stake in Aurora Cannabis during the 1st quarter worth approximately $25,000. Carroll Financial Associates Inc. bought a new stake in Aurora Cannabis during the 1st quarter worth approximately $27,000. Mackey Komara & Dankovich LLC bought a new stake in Aurora Cannabis during the 2nd quarter worth approximately $27,000. Financial Management Professionals Inc. grew its holdings in Aurora Cannabis by 586.3% during the 1st quarter. Financial Management Professionals Inc. now owns 3,061 shares of the company’s stock worth $28,000 after acquiring an additional 2,615 shares during the last quarter. Finally, Executive Wealth Management LLC grew its holdings in Aurora Cannabis by 102.1% during the 2nd quarter. Executive Wealth Management LLC now owns 3,900 shares of the company’s stock worth $30,000 after acquiring an additional 1,970 shares during the last quarter. 9.10% of the stock is currently owned by hedge funds and other institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Recommended Story: How do CD ladders protect against rising interest rates?

Get a free copy of the Zacks research report on Aurora Cannabis (ACB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Cloverdale Capital Management LLC Buys 18,772 Shares of Mohawk Industries, Inc.
Cloverdale Capital Management LLC Buys 18,772 Shares of Mohawk Industries, Inc.
Perspecta Inc  Shares Sold by Cloverdale Capital Management LLC
Perspecta Inc Shares Sold by Cloverdale Capital Management LLC
Eminence Capital LP Invests $12.90 Million in Sothebys
Eminence Capital LP Invests $12.90 Million in Sothebys
Eminence Capital LP Has $26.53 Million Stake in Asbury Automotive Group, Inc.
Eminence Capital LP Has $26.53 Million Stake in Asbury Automotive Group, Inc.
Eminence Capital LP Cuts Holdings in TAKE-TWO INTERACTIVE SOFTWARE, INC
Eminence Capital LP Cuts Holdings in TAKE-TWO INTERACTIVE SOFTWARE, INC
Eminence Capital LP Sells 226,265 Shares of Thermo Fisher Scientific Inc.
Eminence Capital LP Sells 226,265 Shares of Thermo Fisher Scientific Inc.


© 2006-2019 Ticker Report